Haemonetics HAE Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Business | ||||||
| Blood Center | $56.41M+0.7% | $56.56M-19.6% | $56.45M-17.6% | $51.84M-21.7% | $56.01M— | |
| Hospital | $159.65M+8.0% | $143.5M-0.3% | $145.5M+5.1% | $139.66M+4.2% | $147.86M— | |
| Plasma | $130.29M+2.8% | $138.91M+3.5% | $125.36M-9.5% | $129.9M-4.4% | $126.74M— | |
| Total net revenues by Product | ||||||
| Plasma | $130.29M+2.8% | $138.91M+3.5% | $125.36M-9.5% | $129.9M-4.4% | $126.74M-9.1% | |
| Net revenues by Geography | ||||||
| Europe | $52.9M+25.1% | $48.28M+9.3% | $42.97M+2.3% | $40.88M-13.4% | $42.28M+5.6% | |
| Japan | $18.4M+14.3% | $18.14M+12.1% | $18.01M+9.7% | $13.65M-0.4% | $16.11M+10.9% | |
| Other | $3.11M+12.3% | $1.81M-63.3% | $3.68M-30.1% | $2.81M-57.1% | $2.77M-16.6% | |
| Rest of Asia | $19.97M-5.6% | $23.03M-10.0% | $22.57M-12.4% | $21.65M+9.4% | $21.16M-21.3% | |
| United States | $251.97M+1.5% | $247.71M-3.9% | $240.09M-6.2% | $242.4M-2.6% | $248.29M+2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Haemonetics break its business down?
- Haemonetics (HAE) reports net revenues by business across 3 parts — Blood Center, Hospital and Plasma. Each is extracted from the segment footnotes and tracked over time.
- Where does Haemonetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Haemonetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
